Erik Koenig

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.

Pooja Shah, Hua Liao, John Newcomb, 2017, Nature chemical biology.

Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage

Pooja Shah, Hugues Bernard, T. Shinozawa, 2016, Journal of applied toxicology : JAT.

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.

Mark Manfredi, Lenny Dang, Usha Narayanan, 2010, Blood.

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.

Anthony Boral, Paul Richardson, Yongsheng Huang, 2006, Blood.

Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.

Bin Li, Matthew Schu, R. Neuwirth, 2014, Blood.